Market Overview

UPDATE: Albany Molecular Research Shares Down Roughly 20% At $10.27, Fell As Much As 23.3% At Low On Disclosure That Bristol-Myers Squibb Has Canceled Development of Drug With Company

Get Benzinga's Newsletters